Western Financial Corp’s Idexx Laboratories IDXX Stock Holding History

Western Financial Corp’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,076	Closed	-$709K	–	101
2021 Q4	$709K	Buy	1,076 +236	+28%	+$148K	0.37%	63
2021 Q3	$522K	Buy	840 +16	+2%	+$10.8K	0.31%	61
2021 Q2	$520K	Buy	824 +40	+5%	+$22.1K	0.28%	58
2021 Q1	$384K	Buy	784 +39	+5%	+$19.5K	0.23%	63
2020 Q4	$372K	Buy	+745	New	+$333K	0.24%	61

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Western Financial Corp's IDXX Position: Q1 2022 in Review

Western Financial Corp sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 1,076 shares — an estimated $709K sold.

Western Financial Corp first reported a position in IDXX in Q4 2020 and held it in 5 quarters. The position peaked at $709K in Q4 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

Western Financial Corp reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
Western Financial Corp sold 1,076 Idexx Laboratories shares in Q1 2022, an estimated $709K.
Western Financial Corp first reported a position in Idexx Laboratories in Q4 2020 and held it in 5 quarters.
Western Financial Corp's Idexx Laboratories position peaked at $709K in Q4 2021.
1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on Western Financial Corp's 13F filing for Q1 2022, filed 22 Apr 2022.